Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest Inc., which is a biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest Inc.’s technology platform includes a panel of tumor antigen specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent, which is developing antibody-based immunotherapeutic products for cancer in the Greater China territory.


TSXV:QPT - Post by User

Comment by ARIMA11on Feb 24, 2022 1:42pm
177 Views
Post# 34458799

RE:RE:RE:RE:Interesting

RE:RE:RE:RE:Interesting
The possibility for"no money" is there but QPT.V should have a legal option IF it comes to that!
The likelihood is relatively low, in the last release South Korea is a location of one studies.
Also the South Korean government is also involved in funding (K-Master Program).
 
https://questpharmatech.com/wp-content/uploads/2021/09/NR010921.pdf
https://k-master.org/intro_3_e.php;https://k-master.org/intro_4_e.php 
 
However, It may be that more time will be required and that the money might not all flow instantly. That's definitely a factor! Penalty for non payment is granted for up to 4 years.
 
https://questpharmatech.com/wp-content/uploads/2021/03/NR26032021.pdf
 
Pending regulatory approval for the final share payment, OncoQuest has received a 1% interest bearing unsecured OQP corporate bond with a face value of USD$175 million which is due on February 24, 2022 and can be extended annually for up to five years.
 
Yes, today's already the 24th! 
<< Previous
Bullboard Posts
Next >>